Who
Melissa A. Starovasnik
Director
Company insider
Files Form 4 as: Director, Twist Bioscience.
In numbers
- Trades disclosed
- 17
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $611K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 5 Aug 2021
- Last trade
- 28 May 2026
- Last filed
- 1 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 May 2026filed 1 Jun 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $170K2,500 at $68.00 | filing |
| 28 May 2026filed 1 Jun 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $170K2,500 at $68.00 | filing |
| 26 May 2026filed 28 May 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $31K500 at $61.04 | filing |
| 26 May 2026filed 28 May 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $31K500 at $61.04 | filing |
| 27 Apr 2026filed 29 Apr 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $31K500 at $61.83 | filing |
| 27 Apr 2026filed 29 Apr 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $31K500 at $61.83 | filing |
| 1 Apr 2026filed 3 Apr 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $51K1,000 at $51.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $51K1,000 at $51.00 | filing |
| 5 Feb 2026filed 9 Feb 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code A | —5,095 at $0.00 | filing |
| 5 Feb 2026filed 9 Feb 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code A | —5,095 at $0.00 | filing |
| 5 Feb 2025filed 7 Feb 2025 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code A | —4,472 at $0.00 | filing |
| 6 Feb 2024filed 9 Feb 2024 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code A | —5,815 at $0.00 | filing |
| 9 Feb 2023filed 13 Feb 2023 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $46K1,732 at $26.46 | filing |
| 7 Feb 2023filed 9 Feb 2023 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code A | —8,212 at $0.00 | filing |
| 8 Feb 2022filed 10 Feb 2022 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code A | —3,491 at $0.00 | filing |
| 5 Aug 2021filed 10 Aug 2021 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code A | —1,369 at $0.00 | filing |
| 5 Aug 2021filed 10 Aug 2021 | TWST Twist Bioscienceoption or derivative · Genomics & Gene Editing | SEC FORM 4 Code A | —2,739 at $0.00 | filing |
News
Twist Bioscience (NASDAQ:TWST) versus Quanterix (NASDAQ:QTRX) Financial AnalysisTWST · tickerreport.com · 15 Oct 2026
0 headlines in the last 90 days name Melissa A. Starovasnik; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.